CannaTech Tel Aviv & PsyTech Summit Postponed

New Dates

PsyTech Summit: June 14-15, 2020

CannaTech Tel Aviv: June 15-16, 2020

ISRAEL: In light of developing circumstances with the COVID-19 coronavirus and based on recommendations from the Israeli Ministry of Health, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), CannaTech Tel Aviv and PsyTech Summit are postponed.  PsyTech Summit will take place June 14-15 and CannaTech, June 15-16, 2020.

Saul Kaye, CEO of iCAN: Israel-Cannabis commented: “Our number one concern is the health and safety of our attendees and speakers, our partners, our colleagues and our vendors. While we are disappointed to postpone both CannaTech Tel Aviv and PsyTech Summit, we are very confident it will be worth the wait.

“We thank our sponsors and attendees for their understanding and wish all those affected by the virus our very best. We are fully committed to create beautifully crafted events in June that will showcase the brands and solutions that fuel this industry.”

iCAN: Israel-Cannabis And Headquarters Announce Strategic Partnership

ISRAEL: iCAN: Israel-Cannabis, Israel’s leading cannabis incubator and Headquarters (HQ), a Los Angeles based product accelerator and cannabis license holder with distribution and manufacturing facilities, have formed a strategic partnership to identify the most innovative Israeli cannabis companies and products, and provide them with access to the California market, via distribution, sales and marketing support.

Saul Kaye, Founder and CEO of iCAN, commenting on the partnership agreement said, “California is the capital of cannabis innovation in the United States.  Not only is the state America’s most lucrative cannabis market, with over $2 billion in sales a year and growing, it is the global industry trend setter. We are thrilled to partner with the experienced and forward-thinking team at the HQ product accelerator and bring Israel’s renown advanced cannabis technology and solutions to California.”

Daniel Abrahami, CEO & Co-founder of HQ, said, “We’re excited to be partnering with iCAN to build a cannabis bridge between Israel and California. iCAN has developed a world-class ecosystem of cannabis companies and is at the very center of all the amazing developments in the Israeli cannabis industry. Together, iCAN and HQ will introduce the very best of these cannabis innovations to California.”

 

Global Cannabis Business Leaders, Scientists, Technologists & Thought Leaders Gather For CannaTech Cape Town, South Africa, November 24 – 26, 2019

ISRAEL: As the global medical cannabis market continues to expand and increasing numbers of countries around the globe legalize its use, the renowned CannaTech Summit will take place for the first time on the African Continent in Cape Town, South Africa, November 24 – 26 at The Lookout, V&A Waterfront.

With estimates that the cannabis and associated products market could be worth R27 billion by 2023, this immense potential has led to a boom in regional cannabis interest and investment.

CannaTech Cape Town will bring together industry leaders from across the African Continent and around the world known for their significant and ground-breaking contributions to the global medical and recreational cannabis market in all fields including Agricultural Tech and Innovation, Business and Finance, Policy and Regulation, Science and Medicine.

“The global interest in Africa’s cannabis market and South Africa’s recent legislative acceptance of cannabis makes Cape Town the perfect destination for CannaTech. Following South Africa, several African countries, including Swaziland, Malawi, and Zimbabwe, are examining legalizing cannabis cultivation for medical or industrial applications.  We are thrilled to bring some of the world’s leading companies and investors to CapeTown to meet with their counterparts to discuss a range of business and technological issues and work with like minded professionals who understand the immense global health and business potential of medical and recreational cannabis moving forward,” said Saul Kaye, Founder and CEO of iCAN:Israel-Cannabis. “As someone born in South Africa, I am especially looking forward to establishing ties throughout the entire continental cannabis eco-system,” he added.

iCAN: Israel-Cannabis CEO Saul Kaye Comments on New Israeli Cannabis Initiatives

ISRAEL: Kupat Holim Meuhedet, Israel’s third largest health maintenance organization (HMO), announced yesterday that it was opening an internal cannabis unit using a digitalized system that will allow for significantly faster medical cannabis approval for patients in need.

In the framework of the new independent unit, the family doctor will transfer the request of the Meuhedet patient with a recommendation to the unit within the fund, which will approve the request. The process will shorten the generally long wait that typifies the unit of the Ministry of Health.  As a result, other health funds are considering the possibility of setting up similar units.

“We congratulate Meuchedet on their forward-thinking attitude to cannabis medicine and breaking the barriers that currently exist in Israel for patient access. For too long the HMOs have been complacent in the long and complicated process of obtaining medical cannabis in Israel. I hope to see the next news that they are covering the cost of cannabis for reimbursement as part of the medical system in Israel.  Meuchedet is the most supportive Israeli health fund. They have the most doctors who understand the importance of medical cannabis treatment and have the knowledge to prescribe it,” said iCAN: Israel-Cannabis CEO Saul Kaye.

In addition, also yesterday, Israeli news organizations reported that Prime Minister Benjamin Netanyahu will support a bill tabled by Likud MK Sharren Haskel that would, in effect, legalize cannabis by allowing all Israelis to grow one cannabis plant for personal consumption.  Dealing cannabis would remain illegal.

“No one should be criminalized for growing a cannabis plant and using the leaves as they see fit.  This is an important step in the process of decriminalizing cannabis in Israel and I hope this legislation passes soon after the Knesset is back from its summer recess. I have worked closely with MK Haskel on all of her cannabis initiatives and wish her well in the upcoming elections as Israel’s true cannabis voice in the Government,” said Kaye.

China’s Thalys And iCAN: Israel-Cannabis Sign MOU For Co-Investment In Cannabis & Hemp Related Startups

ISRAEL: Thalys Medical Technology, a leading Chinese healthcare conglomerate listed on the Shanghai Stock Exchange (603716.SS), signed a Memorandum of Understanding with iCAN Israel-Cannabis, Israel’s leading medical cannabis incubator. 

iCANN logoThalys and iCAN will come together to create a unique partnership to advance the development of early stage incubated companies that focus on the creation of medical technology, agricultural technology and general intellectual property focusing on the medical hemp industry.  

“Thalys and iCAN each bring unique strengths to this partnership, which is strategic in every sense.  Thalys will help iCAN’s portfolio companies enter the world’s most populous consumer market.  Thalys, which plans to co-invest in iCAN’s portfolio investments that address Chinese market needs, will have exclusive cooperation rights on iCAN’s incubated start-ups and we will have matching stakes in new investments.  I am honoured, humbled and proud to work cooperatively with one of China’s leading medical technology companies,” said Saul Kaye, CEO of iCAN.

According to the MOU, Thalys will have access to all early stage companies that iCAN is evaluating for investment, funding for co-investment, and access to the Israeli market.  Thalys will have the ability to negotiate exclusive rights with any and all of the incubated companies for the Chinese market.

Yicheng Wen, Thalys’ Board Member, stated “By pairing with a leading medical, agricultural, and technology incubator from Israel, known by many as the ‘Start-Up Nation’, Thalys advances its mission to serve the Chinese domestic healthcare market through innovation. We are excited to deepen the relationship between Chinese and Israeli entrepreneurs to accelerate the development of China’s new medical hemp industry.”

International Cannabis Industry Leaders To Convene At The CannaTech House In Davos, Switzerland

Screenshot 2019-01-14 08.01.32ISRAEL:  The world’s top cannabis industry leaders will convene in an unprecedented gathering in Davos, Switzerland from January 22-25.  Ehud Barak, former Israeli Prime Minister and Chairman of InterCure, Roei Zerahia CEO CANNDOC, Yona Levy CEO of Alvit and Tefen, Eyal Barad CEO Cannabics,  Lorne Gertner Chairman of Hiku Brands, Jason Warnock CEO of TheraCann and Saul Kaye CEO of iCAN: Israel Cannabis are just some of the industry leaders that will participate at the CannaTech Pavilion events in Davos.

“I am thrilled that CannaTech will be co-hosting the Canada Cannabis House along with the Canadian Securities Exchange (CSE), OTC markets, and Kapoor Capital in Davos. CannaTech has been widely claimed as the “Davos” of Cannabis conferences and it is an honor to participate there and help regulators and industry giants understand the impact of this emerging industry on a global level.  The burgeoning cannabis industry is poised to revolutionize patient care and the leisure industry and these changes are creating new international ecosystems that will have massive impact, from local farm workers to the world’s largest corporations.  Cannabis is part and parcel of the next wave of globalization and a serious discussion in Davos could not be more timely,” said iCAN’s Saul Kaye.

Schedule of Events:
Tuesday, Jan 22nd 4-6:00 pm

Welcoming RemarksCannabis in the Capital Markets – What’s Getting Funded Next?USA vs. Canada Vik Kapoor & Saul KayeRichard Carleton (CSE), Jason Paltrowitz (OTC), and Dan Daviau (Canaccord); Moderated by James Black (CSE)Bruce Linton (Canopy), Kevin Murphy (Acreage)

Wednesday Jan 23rd 3:00-5:00 pm

Cannabis 3.0The Next Investment Opportunities in Global Cannabis ExpansionHow to Build International Brands in the Cannabis Industry Lorne Gertner (Hiku)Prakash Hariharan (Radient), Boris Blatnik (KannaSwiss), Antonio Costanzo (EMMAC); Moderated byPaul Sparkes (Invictus), Mike Dacks (Plena); Moderated by Mark Goldhar (Civilized)

Thursday Jan 24th 3:30-6:00 pm

An interview with Ehud Barak
10th Prime Minister of Israel
Ehud Barak interviewed by Anthony Scaramucci
Emerging Markets – Asia & LATAM Philip Gu (SCU/Casnnacubed), Stuart Bobrow (Cannahub); Moderated by Raymond D. Harari (Canalis Capital)
Exporting Cannabis Innovation to the WorldCannabis 2020 and beyond Yona Levy (Alvit Israel), Roei Zerahia (CANNDOC Israel), Jason Warnock (TheraCann), Eyal Barad (Cannabics Israel)Antonio Costanzo (EMMAC)

 

iCAN: Israel Cannabis CEO: “Cannabis to Become as Important to Israel’s Economy as High-Tech”

ISRAEL: In a long-awaited move, the Knesset, Israel’s Parliament, has finally approved the export of medical cannabis allowing Israel to fully participate in the exploding cannabis industry world-wide.

Saul Kaye, CEO of iCAN: Israel-Cannabis issued the following statement:

“This is a long overdue but welcome development.  iCAN has been diligently working together with Israeli regulators to further the growth of the cannabis industry with the goal of having Israel become the leading global export nation of medical cannabis.

Israel, already the most advanced nation in cannabis R&D will now be able to produce and market cannabis and cannabis-based products that will help millions of people suffering from illnesses including cancer, MS, Parkinson’s, sleep disorders, epilepsy, and PTSD, to name just a few.

Israel’s expertise in the field extends from cultivation and processing to research and development.  By law, Israeli companies will be subject to strict supervision and maintain high medical grade standards. Israel is perfectly positioned to enter and disrupt the medical cannabis market that is expected to soar to $33 billion dollars worldwide in the next 5 years.  In Israel alone, we quickly expect over $1 billion in sales to countries interested in our products.

“We are proud of our forward-thinking government and will continue to work together to build the industry and help patients world-wide access safe, quality medical cannabis.”

The law, which passed today, provides a budget that allows the Interior Ministry and specifically the Israeli Police, to monitor, track and control the production and delivery of cannabis for export, and ensure there is no risk of leakage to the local illegal drug market. iCAN, through its partner Theracann, has secured the technology that can power the police and Ministry of Health in Israel and provide complete transparency and tracking of every gram of cannabis both for export and the local market.

The new law also specifies that any foreign investment of more than 5% in an Israeli cannabis company will require regulatory approval.